Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments

Journal of Virology

Volumn 77, Issue 9, 2003, Pages 5540-5546

  Nickle, David C ^a   Jensen, Mark A ^a   Shriner, Daniel ^a   Brodie, Scott J ^a   Frenkel, Lisa M ^a,b   Mittler, John E ^a   Mullins, James I ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA; VIRUS RNA;

ALGORITHM; ARTICLE; CELL TYPE; COMPUTER SIMULATION; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; TISSUE TYPES; VIRUS ISOLATION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; DISEASE RESERVOIRS; DNA, VIRAL; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; PREDICTIVE VALUE OF TESTS; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0037405163     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.9.5540-5546.2003     Document Type: Article

References (41)

1. Beerli, P., and J. Felsenstein. 2001. Maximum likelihood estimation of a migration matrix and effective population sizes in n subpopulations by using a coalescent approach. Proc. Natl. Acad. Sci. USA 98:4563-4568.
2. Beerli, P., N. C. Grassly, M. K. Kuhner, D. Nickle, O. Pybus, M. Rain, A. Rambaut, A. G. Rodrigo, and Y. Wang. 2000. Population genetics of HIV: parameter estimation using genealogy-based methods, p. 217-258. In A. G. Rodrigo and G. H. Learn (ed.), Computational and evolutionary analyses of HIV sequences. Kluwer Academic Publishers, Boston, Mass.
3. Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
4. Bourinbaiar, A. S. 1994. The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol. 38:59-61.
5. Chun, T. W., R. T. Davey, Jr., M. Ostrowski, J. S. Justement, D. Engel, J. I. Mullins, and A. S. Fauci. 2000. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med. 6:757-761.
6. + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869-8873.
7. Chun, T. W., and A. S. Fauci. 1999. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc. Natl. Acad. Sci. USA 96:10958-10961.
8. Collins, K. R., M. E. Quinones-Mateu, Z. Toossi, and E. J. Arts. 2002. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev. 4:165-176.
9. Coombs, R., C. Speck, J. Hughes, W. Lee, R. Sampoleo, S. Ross, J. Dragavon, G. Peterson, T. Hooton, A. Collier, L. Corey, L. Koutsky, and J. Krieger. 1998. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J. Infect. Dis. 177:320-330.
10. Delwart, E., J. Mullins, P. Gupta, G. Learn, M. Holodniy, D. Katzenstein, B. Walker, and M. Singh. 1998. Human immunodeficiency virus type 1 populations in blood and semen. J. Virol. 72:617-623.
11. Drummond, A., and A. G. Rodrigo. 2000. Reconstructing genealogies of serial samples under the assumption of a molecular clock using serial-sample UPGMA. Mol. Biol. Evol. 17:1807-1815.
12. Felsenstein, J. 1993. PHYLIP (Phylogeny Inference Package) version 3.5c. University of Washington, Seattle, Wash.
13. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
14. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
15. Hartl, D. L., and A. G. Clark. 1989. Principles of population genetics, 2nd ed. Sinauer Associates, Sunderland, Mass.
16. Hudson, R. R. 1990. Gene genealogies and the coalescent process. Oxf. Surv. Evol. Biol. 7:1-14.
17. Imamichi, H., K. A. Crandall, V. Natarajan, M. K. Jiang, R. L. Dewar, S. Berg, A. Gaddam, M. Bosche, J. A. Metcalf, R. T. Davey, Jr., and H. C. Lane. 2001. Human immunodeficiency virus type 1 quasispecies that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasispecies present before initiation of therapy. J. Infect. Dis., 183:36-50.
18. Jensen, M. A., B. Charlesworth, and M. Kreitman. 2002. Patterns of genetic variation at a chromosome 4 locus of Drosophila melanogaster and D. simulans. Genetics 160:493-507.
19. Keys, B., J. Karis, B. Fadeel, A. Valentin, G. Norkrans, L. Hagberg, and F. Chiodi. 1993. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196:475-483.
20. Kiessling, A. A., L. M. Fitzgerald, D. Zhang, H. Chhay, D. Brettler, R. C. Eyre, J. Steinberg, K. McGowan, and R. A. Byrn. 1998. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res. Hum. Retrovir. 14(Suppl. 1):S33-S41.
21. Korber, B. T., K. MacInnes, R. F. Smith, and G. Myers. 1994. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J. Virol. 68:6730-6744.
22. Kusumi, K., B. Conway, S. Cunningham, A. Berson, C. Evans, A. K. N. Iversen, D. Colvin, M. V. Gallo, S. Coutre, E. G. Shpaer, D. V. Faulkner, A. DeRonde, S. Volkman, C. Williams, M. S. Hirsch, and J. I. Mullins. 1992. HIV-1 envelope gene structure and diversity in vivo and following cocultivation in vitro. J. Virol. 66:875-885.
23. Leigh Brown, A. J. 1997. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94:1862-1865.
24. Maddison, W. P., and D. R. Maddison. 2001. MacClade - analysis of phylogeny and character evolution - version 4. Sinauer Associates, Inc., Sunderland, Mass.
25. Mellors, J., L. Kingsley, C. Rinaldo, J. Todd, B. Hoo, R. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
26. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
27. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1 infected compartments during therapy. Nature 387:189-191.
28. Poss, M., A. G. Rodrigo, J. J. Gosink, G. H. Learn, D. de Vange Panteleeff, H. L. Martin, Jr., J. Bwayo, J. K. Kreiss, and J. Overbaugh. 1998. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J. Virol. 72:8240-8251.
29. Press, W. H., and Numerical Recipes Software. 1994. Numerical recipes in C, version 2.04, 2nd ed. Cambridge University Press, New York, N.Y.
30. Ramratnam, B., J. E. Mittler, L. Zhang, D. Boden, A. Hurley, F. Fang, C. A. Macken, A. S. Perelson, M. Markowitz, and D. D. Ho. 2000. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat. Med. 6:82-85.
31. Rodrigo, A. G., E. G. Shpaer, E. L. Delwart, A. K. N. Iversen, M. V. Gallo, J. Brojatsch, M. S. Hirsch, B. D. Walker, and J. I. Mullins. 1999. Coalescent estimates of HIV-1 generation time in vivo. Proc. Natl. Acad. Sci. USA 96:2187-2191.
32. Ruff, C. T., S. C. Ray, P. Kwon, R. Zinn, A. Pendleton, N. Hutton, R. Ashworth, S. Gange, T. C. Quinn, R. F. Siliciano, and D. Persaud. 2002. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J. Virol. 76:9481-9492.
33. Schacker, T. W., J. P. Hughes, T. Shea, R. W. Coombs, and L. Corey. 1998. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 128:613-620.
34. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X. L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
35. Siliciano, R. 2000. Can antiretroviral therapy ever be stopped? AIDS Read. 10:224-229.
36. Slatkin, M., and W. P. Maddison. 1989. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 123:603-613.
37. Slatkin, M., and W. P. Maddison. 1990. Detecting isolation by distance using phylogenies of genes. Genetics 126:249-260.
38. Swofford, D. L. 1999. PAUP 4.0: Phylogenetic analysis using parsimony (and other methods), version 4.0, 2nd ed. Sinauer Associates, Inc., Sunderland, Mass.
39. Wares, J. P., S. D. Gaines, and C. W. Cunningham. 2001. A comparative study of asymmetric migration events across a marine biogeographic boundary. Evol. Int. J. Org. Evol. 55:295-306.
40. Zhang, L., C. Chung, B. S. Hu, T. He, Y. Guo, A. J. Kim, E. Skulsky, X. Jin, A. Hurley, B. Ramratnam, M. Markowitz, and D. D. Ho. 2000. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Investig. 106:839-845.
41. Zhang, L., B. Ramratnam, K. Tenner-Racz, Y. He, M. Vesanen, S. Lewin, A. Talal, P. Racz, A. S. Perelson, B. T. Korber, M. Markowitz, and D. D. Ho. 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340:1605-1613.